Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nine-month sales growth in Russia offset Stada's decline in Serbia

This article was originally published in Scrip

Executive Summary

Stada, one of the largest Germany-based wholesalers, increased its sales by 3% to €1.2 billion in the first nine months of this year. The company attributed its modest performance mainly to liquidity problems of its subsidiaries in Serbia, one of its most important individual markets. These problems resulted from hospitals' non-payments and/or delayed payments to wholesalers.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC010899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel